Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Breast 2Sarcoma 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 25Multiple Myeloma 20Recurrence 19Lymphoma, Non-Hodgkin 16Lymphoma 15Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma, B-Cell 13Hematologic Neoplasms 12Ovarian Neoplasms 10Melanoma 10Leukemia 10Myeloproliferative Disorders 9Burkitt Lymphoma 9Lymphoma, Large B-Cell, Diffuse 8Hodgkin Disease 8Pancreatic Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Osteosarcoma 6Neuroblastoma 6Neoplasms 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Myelomonocytic, Chronic 6Breast Neoplasms 6Neoplasm Metastasis 5Lymphoma, Mantle-Cell 5

Interventions

Nivolumab 34pembrolizumab 29cabozantinib 26Specimen Handling 25Magnetic Resonance Spectroscopy 22Ipilimumab 19lenvatinib 15belzutifan 13Axitinib 13Sunitinib 9CTLA-4 Antigen 9Radiosurgery 8Biopsy 8atezolizumab 6Everolimus 5toripalimab 4spartalizumab 4fludarabine 4cemiplimab 4avelumab 4aldesleukin 4Immunoglobulin G 4Cyclophosphamide 4zimberelimab 3tivozanib 3pazopanib 3palbociclib 3durvalumab 3X-Rays 3Surveys and Questionnaires 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × fludarabine × 90 days × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07564232 2026-05-04

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

M.D. Anderson Cancer Center

Phase 1 Not yet recruiting
40 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07551349 2026-04-24

DUAL-NK RCC

Beijing Biotech

Phase 1/2 Recruiting
36 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms

NCT02830724 2026-04-06

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
124 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡